Profilo
Wolfgang Barth is currently working as a Development Director at AC Immune SA since 2013.
Previously, he held positions as a Director-Project Management at Bayer Corp., a Principal at Bayer AG, and a Member-Supervisory Board at Hypothekenbank Frankfurt AG.
From 2004 to 2008, he served as a Vice President-Development at Avontec GmbH.
He also worked as the Head-Development at TRIN Pharma GmbH.
Dr. Barth holds a doctorate degree from Philipps University of Marburg.
Precedenti posizioni note di Wolfgang Barth
| Società | Posizione | Fine |
|---|---|---|
Avontec GmbH
Avontec GmbH Pharmaceuticals: MajorHealth Technology Discovers and develops novel therapeutic treatments for inflammatory disease | Corporate Officer/Principal | 18/06/2008 |
Hypothekenbank Frankfurt AG
Hypothekenbank Frankfurt AG Financial ConglomeratesFinance Mortgage Bank | Direttore/Membro del Consiglio | 13/07/2006 |
TRIN Pharma GmbH
TRIN Pharma GmbH Medical/Nursing ServicesHealth Services Develops small molecule drugs for an effective tumor treatment | Corporate Officer/Principal | - |
| AC IMMUNE SA | Corporate Officer/Principal | - |
| BAYER AG | Corporate Officer/Principal | - |
Formazione di Wolfgang Barth
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 7 |
|---|---|
Bayer Corp.
Bayer Corp. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical, healthcare & agricultural products | Health Technology |
Bayer AG
Bayer AG Pharmaceuticals: MajorHealth Technology Provides health care, nutrition and high-tech material services | Health Technology |
AC Immune SA
AC Immune SA Pharmaceuticals: MajorHealth Technology Manufactures precision medicines for neurodegenerative diseases | Health Technology |
Hypothekenbank Frankfurt AG
Hypothekenbank Frankfurt AG Financial ConglomeratesFinance Mortgage Bank | Finance |
Avontec GmbH
Avontec GmbH Pharmaceuticals: MajorHealth Technology Discovers and develops novel therapeutic treatments for inflammatory disease | Health Technology |
Philipps University of Marburg
Philipps University of Marburg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
TRIN Pharma GmbH
TRIN Pharma GmbH Medical/Nursing ServicesHealth Services Develops small molecule drugs for an effective tumor treatment | Health Services |
















